Quantcast

Latest Triple-negative breast cancer Stories

2013-10-01 23:00:50

A major Department of Defense grant to researchers Jennifer Richer, PhD, and Anthony Elias, MD, at the University of Colorado Cancer Center aids development of drugs that target androgen receptors as a driver of breast cancer. AURORA, Colo. (PRWEB) October 01, 2013 A major Department of Defense grant to researchers Jennifer Richer, PhD, and Anthony Elias, MD, at the University of Colorado Cancer Center aids development of drugs that target androgen receptors as a driver of breast cancer....

2013-07-26 16:20:02

Singapore, July 27, 2013 - (ACN Newswire) - Scientists at A*STAR's Genome Institute of Singapore (GIS) led in a study that has identified genes that are potential targets for therapeutic drugs against aggressive breast cancer. These findings were reported in the July 2013 issue of PNAS. Out of the 1.5 million women diagnosed with breast cancer in the world annually, nearly one in seven of these is classified as triple negative. Patients with triple- negative breast cancer (TNBC) have tumours...

New Compound BH3 Mimetics Future Of Breast Cancer Treatment
2013-07-09 09:40:18

[ Watch the Video: New Anti-Cancer Compound Shows Promise For Breast Cancer ] Rebekah Eliason for redOrbit.com - Your Universe Online Scientists from Melbourne, Australia recently discovered compounds currently being researched to treat leukemia may also be effective in treating the most common form of breast cancer. Researchers found a group of anti-cancer compounds known as BH3-mimetics are effective for treating estrogen receptor-positive (ER-positive) forms of breast cancers when...

2013-06-25 23:27:40

Centrose announces the issuance of the first patent that covers a new class of antibody drug conjugates. The patent covers a new cancer drug candidate for treating metastatic drug resistant cancers. Madison, Wisconsin (PRWEB) June 25, 2013 Centrose, a company focused on developing safer and more effective therapies that improve patient health, announced today that the United States Patent and Trademark Office (USPTO) issued Centrose its first Extracellular Drug Conjugate (EDC) Patent....


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'